BNTX Stock Analysis: Buy, Sell, or Hold?
BNTX - BioNTech SE American Depositary Share
$113.75
-3.02 (-2.59%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 09, 2026
Get Alerted When BNTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BNTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: BNTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BNTX is currently trading at $113.75, which is considered extended relative to its 30-day fair value range of $94.85 to $112.90.
Technical Outlook: Technically, BNTX is in a uptrend. Immediate support is located at $105.10, while resistance sits at $124.00.
Market Sentiment: BNTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $140.42 (+23.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BNTX is in a uptrend. Immediate support is located at $105.10, while resistance sits at $124.00.
Market Sentiment: BNTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $140.42 (+23.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$94.85 -
$112.90
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.5% below Wall St target ($140.42)
Fair Price Analysis
30-Day Fair Range
$94.85 -
$112.90
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$105.10
Resistance Level
$124.00
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-51.82
Wall Street Target
$140.42
(+23.5%)
Revenue Growth (YoY)
22.0%
Earnings Growth (YoY)
-43.2%
Profit Margin
-18.1%
Last updated: February 01, 2026 8:05 AM ET
Data refreshes hourly during market hours. Next update: 9:05 AM
Data refreshes hourly during market hours. Next update: 9:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced BNTX Option Strategies
Professional options setups generated by AI based on today's BNTX price and gamma walls.
